Form 4: UL Solutions Executive Reports Accrual of Dividend Equivalent Rights on Restricted Stock Units

Sentiment:

Insider Transaction Report


UL Solutions Inc.'s EVP & CCO, Alberto Uggetti, has reported the routine accrual of dividend equivalent rights on his restricted stock units, a standard compensation-related transaction.

Summary

  • Alberto Uggetti, Executive Vice President & Chief Commercial Officer (EVP & CCO) of UL Solutions Inc. (ULS), reported the accrual of dividend equivalent rights on his restricted stock units (RSUs).
  • The transaction date for these accruals was June 9, 2025.
  • A total of 13 dividend equivalent rights were accrued across three different tranches of RSUs (4, 5, and 4 rights respectively).
  • Each dividend equivalent right represents a contingent right to receive one share of UL Solutions' Class A Common Stock.
  • These dividend equivalent rights vest proportionately with the underlying restricted stock units.
  • The underlying restricted stock units vest in three equal installments on the anniversaries of May 1, 2024, January 1, 2025, and April 1, 2025, depending on the specific tranche.
  • Following these transactions, Mr. Uggetti beneficially owns 2,261, 3,019, and 2,597 derivative securities (RSUs and accrued dividend equivalent rights) across the respective tranches.
  • Historically, dividend equivalent rights were reported separately but are now aggregated with the underlying restricted stock units in this Form 4 and will continue to be reported together.

Sentiment

Score: 6

Explanation: The filing is neutral in nature, detailing a routine executive compensation event. The accrual of equity-linked compensation is generally a positive sign of alignment, but it's not a significant market-moving event on its own.

Positives

  • The accrual of dividend equivalent rights indicates ongoing executive compensation, aligning management's interests with shareholder value through equity ownership.

Negatives

  • No negative aspects are directly indicated by this routine compensation-related filing.

Risks

  • No specific risks are mentioned in this Form 4 filing, which primarily details executive compensation transactions.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook, as it is a disclosure of an executive's equity compensation.

Industry Context

This Form 4 filing is a routine disclosure of executive equity compensation and does not provide broader industry context or trends. Such filings are standard practice for publicly traded companies to ensure transparency regarding insider holdings and transactions.

Stakeholder Impact

  • Shareholders: The filing provides transparency regarding executive equity compensation, which aligns management's interests with shareholder value over the long term.
  • Employees: No direct impact on general employees is indicated by this filing.

Next Steps

  • The restricted stock units and their associated dividend equivalent rights will continue to vest in equal installments on the anniversaries of their respective grant dates (May 1, 2024, January 1, 2025, and April 1, 2025).
  • Future Form 4 filings will aggregate dividend equivalent rights with the underlying restricted stock units.

Key Dates

DateDescription
05/01/2024Base date for vesting schedule of a tranche of restricted stock units.
01/01/2025Base date for vesting schedule of a tranche of restricted stock units.
04/01/2025Base date for vesting schedule of a tranche of restricted stock units.
06/09/2025Date of transaction for the accrual of dividend equivalent rights on restricted stock units.
06/11/2025Date the Form 4 was signed by the attorney-in-fact.

Keywords

UL Solutions, ULS, Form 4, SEC Filing, Insider Transaction, Restricted Stock Units, RSU, Dividend Equivalent Rights, Executive Compensation, Alberto Uggetti, Equity Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.